Patient-derived xenografts and single-cell sequencing identifies three subtypes of tumor-reactive lymphocytes in uveal melanoma metastases
Preprint
- 11 July 2024
- preprint
- Published by eLife Sciences Publications, Ltd in eLife preprints
- Vol. 12
Abstract
Uveal melanoma (UM) is a rare melanoma originating in the eye’s uvea, with 50% of patients experiencing metastasis predominantly in the liver. In contrast to cutaneous melanoma, there is only a limited effectiveness of combined immune checkpoint therapies, and half of patients succumb to recurrent disease after two years. This study aimed to provide a path towards enhancing immunotherapy efficacy by identifying and functionally validating tumor-reactive T cells in liver metastases of patients with UM. We employed single-cell RNA sequencing of biopsies and tumor-infiltrating lymphocytes (TILs) to identify potential tumor-reactive T cells. Patient-derived xenograft (PDX) models of UM metastases were created from patients, and tumor sphere cultures were generated from these models for co-culture with autologous or MART1-specific HLA-matched allogenic TILs. Activated T cells were subjected to TCR sequencing, and the TCRs were matched to those found in single-cell sequencing data from biopsies, expanded TILs and in livers or spleens of PDX models injected with TILs. Our findings revealed that tumor-reactive T cells resided not only among activated and exhausted subsets of T cells, but also in a subset of cytotoxic effector cells. In conclusion, combining single-cell sequencing and functional analysis provides valuable insights into which T cells in UM may be useful for cell therapy amplification and marker selection.Keywords
All Related Versions
This publication has 56 references indexed in Scilit:
- Genetics and Therapeutic Responses to Tumor-Infiltrating Lymphocyte Therapy of Pancreatic Cancer Patient-Derived Xenograft ModelsGastro Hep Advances, 2022
- Transcriptomic profiles of neoantigen-reactive T cells in human gastrointestinal cancersCancer Cell, 2022
- Senescent T cells: a potential biomarker and target for cancer therapyEBioMedicine, 2021
- Melanoma models for the next generation of therapiesCancer Cell, 2021
- Supporting clinical decision making in advanced melanoma by preclinical testing in personalized immune-humanized xenograft mouse modelsAnnals of Oncology, 2020
- Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human MelanomaCell, 2018
- Clinical outcomes in metastatic uveal melanoma treated with PD‐1 and PD‐L1 antibodiesCancer, 2016
- Systemic treatment of metastatic uveal melanoma: review of literature and future perspectivesCancer Medicine, 2013
- T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironmentCurrent Opinion in Immunology, 2013
- FCRL6 distinguishes mature cytotoxic lymphocytes and is upregulated in patients with B‐cell chronic lymphocytic leukemiaEuropean Journal of Immunology, 2008